作者: Manuel Macia , Juan Avilés , Juan Navarro , Silvia Morales , Javier Garcı́a
DOI: 10.1016/S0002-9343(02)01354-2
关键词: Doxycycline 、 Medicine 、 Borrelia burgdorferi 、 Dermatology 、 Azithromycin 、 Ceftriaxone 、 Cefuroxime 、 Pathology 、 Lyme disease 、 Babesiosis 、 Cholestasis 、 General Medicine
摘要: ifestations of Lyme disease. Ann Intern Med. 1983;99:76 –82. 18. Luft BJ, Steinman CR, Neimark HC, et al. Invasion the central nervous system by Borrelia burgdorferi in acute disseminated infection. JAMA. 1992;267:1364 –1367. 19. Krause PJ, Telford SR, Spielman A, Concurrent disease and babesiosis: evidence for increased severity duration illness. 1996;275:1657–1660. 20. Dattwyler RJ, Volkman DJ, Conaty SM, Amoxycillin plus probenecid versus doxycycline treatment erythema migrans borreliosis. Lancet. 1990;336:1404 –1406. 21. Massarotti EM, Luger SW, Rahn DW, Treatment early Am J 1992;92:396 –403. 22. Nadelman RB, Frank E, Comparison cefuroxime axetil 1992;117:273–280. 23. Kunkel MJ, Ceftriaxone compared with N Engl 1997;337:289 –294. 24. Wormser GP, Practice guidelines Clin Infect Dis. 2000;31(suppl 1):S1–S14. 25. Walker DH Task Force on Consensus Approach Erhlichiosis. Diagnosing human ehrlichiosis: current status recommendations. ASM News. 2000;66:287–289. 26. Lepore T, Sikand VK, Atovaquone azithromycin babesiosis. 2000;343: 1454 –1458.